Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 135048, 12 pages
http://dx.doi.org/10.1155/2014/135048
Research Article

Antitumor Effects of Saffron-Derived Carotenoids in Prostate Cancer Cell Models

1Laboratory of Radiobiology, Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, 67100 L’Aquila, Italy
2Section of Medical Pathophysiology, Food Science and Endocrinology, Department of Experimental Medicine, University of Rome “La Sapienza”, 00161 Rome, Italy
3Area of Physiology, Department of Medical Sciences, School of Medicine and Regional Centre for Biomedical Research (CRIB), University of Castilla-La Mancha, 02006 Albacete, Spain
4Cátedra Química Agricola, Universidad de Castilla-La Mancha, Avenida de España s/n., 02071 Albacete, Spain
5Department of Health Sciences, University of L’Aquila, 67100 L’Aquila, Italy
6Department of Biotechnological and Applied Clinical Sciences, Division of Radiotherapy, San Salvatore Hospital, University of L’Aquila, 67100 L’Aquila, Italy
7Department of Clinical and Applied Sciences and Biotechnologies, School of Sexology, University of L’Aquila, 67100 L’Aquila, Italy
8Albacete Science and Technology Park, Avenida de la Innovacion, 02006 Albacete, Spain

Received 6 February 2014; Accepted 12 April 2014; Published 11 May 2014

Academic Editor: Andrea Maria Isidori

Copyright © 2014 Claudio Festuccia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. A. Holstein and R. J. Hohl, “Isoprenoids: remarkable diversity of form and function,” Lipids, vol. 39, no. 4, pp. 293–309, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. F. I. Abdullaev and E. González De Mejía, “Antitumor activity of natural substances: lectins and saffron,” Archivos Latinoamericanos de Nutricion, vol. 47, no. 3, pp. 195–202, 1997. View at Google Scholar · View at Scopus
  3. M. Carmona, A. Zalacain, A. M. Sánchez, J. L. Novella, and G. L. Alonso, “Crocetin esters, picrocrocin and its related compounds present in Crocus sativus stigmas and Gardenia jasminoides fruits. Tentative identification of seven new compounds by LC-ESI-MS,” Journal of Agricultural and Food Chemistry, vol. 54, no. 3, pp. 973–979, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Deo, “Growing saffron—the world's most expensive spice,” Crop and Food Research, vol. 20, no. 1, pp. 1–4, 2003. View at Google Scholar
  5. J. P. Melnyk, S. Wang, and M. F. Marcone, “Chemical and biological properties of the world's most expensive spice: saffron,” Food Research International, vol. 43, no. 8, pp. 1981–1989, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. C. C. Licón, M. Carmona, A. Molina, and M. I. Berruga, “Chemical, microbiological, textural, color, and sensory characteristics of pressed ewe milk cheeses with saffron (Crocus sativus L.) during ripening,” Journal of Dairy Science, vol. 95, no. 8, pp. 4263–4274, 2012. View at Google Scholar
  7. L. Cossignani, E. Urbani, M. S. Simonetti, A. Maurizi, C. Chiesi, and F. Blasi, “Characterisation of secondary metabolites in saffron from central Italy (Cascia, Umbria),” Food Chemistry, vol. 143, pp. 446–451, 2014. View at Google Scholar
  8. C. Ulbricht, J. Conquer, D. Costa et al., “An evidence-based systematic review of saffron (Crocus sativus) by the natural standard research collaboration,” Journal of Dietary Supplements, vol. 8, no. 1, pp. 58–114, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. F. I. Abdullaev and J. J. Espinosa-Aguirre, “Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials,” Cancer Detection and Prevention, vol. 28, no. 6, pp. 426–432, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Deng, Z.-G. Guo, Z.-L. Zeng, and Z. Wang, “Studies on the pharmacological effects of saffron(Crocus sativus L.)—a review,” Zhongguo Zhongyao Zazhi, vol. 27, no. 8, pp. 565–568, 2002. View at Google Scholar · View at Scopus
  11. M. Carmona, A. Zalacain, M. R. Salinas, and G. L. Alonso, “A new approach to saffron aroma,” Critical Reviews in Food Science and Nutrition, vol. 47, no. 2, pp. 145–159, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. D'Alessandro, A. Mancini, A. R. Lizzi et al., “Crocus sativus stigma extract and its major constituent crocin possess significant antiproliferative properties against human prostate cancer,” Nutrition and Cancer, vol. 65, no. 6, pp. 930–942, 2013. View at Google Scholar
  13. J. Tavakkol-Afshari, A. Brook, and S. H. Mousavi, “Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines,” Food and Chemical Toxicology, vol. 46, no. 11, pp. 3443–3447, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. C. Nair, B. Pannikar, and K. R. Panikkar, “Antitumour activity of saffron (Crocus sativus),” Cancer Letters, vol. 57, no. 2, pp. 109–114, 1991. View at Publisher · View at Google Scholar · View at Scopus
  15. S. H. Mousavi, J. Tavakkol-Afshari, A. Brook, and I. Jafari-Anarkooli, “Role of caspases and Bax protein in saffron-induced apoptosis in MCF-7 cells,” Food and Chemical Toxicology, vol. 47, no. 8, pp. 1909–1913, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. D. G. Chryssanthi, P. G. Dedes, N. K. Karamanos, P. Cordopatis, and F. N. Lamari, “Crocetin inhibits invasiveness of MDA-MB-231 breast cancer cells via downregulation of matrix metalloproteinases,” Planta Medica, vol. 77, no. 2, pp. 146–151, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. H. H. Aung, C. Z. Wang, M. Ni et al., “Crocin from Crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells,” Experimental Oncology, vol. 29, no. 3, pp. 175–180, 2007. View at Google Scholar · View at Scopus
  18. A. Bolhassani, A. Khavari, and S. Z. Bathaie, “Saffron and natural carotenoids: biochemical activities and anti-tumor effects,” Biochimica et Biophysica Acta, vol. 1845, no. 1, pp. 20–30, 2014. View at Google Scholar
  19. I. Das, S. Das, and T. Saha, “Saffron suppresses oxidative stress in DMBA-induced skin carcinoma: a histopathological study,” Acta Histochemica, vol. 112, no. 4, pp. 317–327, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Premkumar, S. K. Abraham, S. T. Santhiya, and A. Ramesh, “Protective effects of saffron (Crocus sativus Linn.) on genotoxins-induced oxidative stress in Swiss albino mice,” Phytotherapy Research, vol. 17, no. 6, pp. 614–617, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. F. I. Abdullaev and G. D. Frenkel, “The effect of saffron on intracellular DNA, RNA and protein synthesis in malignant and non-malignant human cells,” BioFactors, vol. 4, no. 1, pp. 43–45, 1992. View at Google Scholar · View at Scopus
  22. E. García-López, A. González-Gallardo, A. Antaramián et al., “In vitro conversion of β-carotene to retinal in bovine rumen fluid by a recombinant β-carotene- 15, 15′-monooxygenase,” International Journal for Vitamin and Nutrition Research, vol. 82, no. 2, pp. 94–103, 2012. View at Google Scholar
  23. J. Molnár, M. D. Kars, U. Gündüz et al., “Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp,” Acta Histochemica, vol. 111, no. 4, pp. 329–333, 2009. View at Google Scholar · View at Scopus
  24. S. K. . Noureini and M. Wink, “Antiproliferative effects of crocin in HepG2 cells by telomerase inhibition and hTERT down-regulation,” Asian Pacific Journal of Cancer Prevention, vol. 13, no. 5, pp. 2305–2309, 2012. View at Google Scholar
  25. A. Kyriakoudi, M. Z. Tsimidou, Y. C. O'Callaghan, K. Galvin, and N. M. O'Brien, “Changes in total and individual crocetin esters upon in vitro gastrointestinal digestion of saffron aqueous extracts,” Journal of Agricultural and Food Chemistry, vol. 61, no. 22, pp. 5318–5327, 2013. View at Google Scholar
  26. A. M. Sánchez, M. Carmona, S. A. Ordoudi, M. Z. Tsimidou, and G. L. Alonso, “Kinetics of individual crocetin ester degradation in aqueous extracts of saffron (Crocus sativus L.) upon thermal treatment in the dark,” Journal of Agricultural and Food Chemistry, vol. 56, no. 5, pp. 1627–1637, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. M. Sánchez, M. Carmona, A. Zalacain, J. M. Carot, J. M. Jabaloyes, and G. L. Alonso, “Rapid determination of crocetin esters and picrocrocin from saffron spice (Crocus sativus L.) using UV-visible spectrophotometry for quality control,” Journal of Agricultural and Food Chemistry, vol. 56, no. 9, pp. 3167–3175, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. M. E. Kaighn, J. F. Lechner, K. Shankar Narayan, and L. W. Jones, “Prostate carcinoma: tissue culture cell lines,” National Cancer Institute Monograph, vol. 49, pp. 17–21, 1978. View at Google Scholar · View at Scopus
  29. R. M. Sramkoski, T. G. Pretlow II, J. M. Giaconia et al., “A new human prostate carcinoma cell line, 22Rv1,” In Vitro Cellular and Developmental Biology—Animal, vol. 35, no. 7, pp. 403–409, 1999. View at Google Scholar · View at Scopus
  30. G. L. Gravina, F. Marampon, I. Giusti et al., “Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models,” International Journal of Oncology, vol. 40, no. 3, pp. 711–720, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Festuccia, P. Muzi, G. L. Gravina et al., “Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro,” International Journal of Oncology, vol. 30, no. 1, pp. 193–200, 2007. View at Google Scholar · View at Scopus
  32. C. Festuccia, C. Vincentini, A. B. Di Pasquale et al., “Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma,” Oncology Research, vol. 7, no. 3-4, pp. 131–138, 1995. View at Google Scholar · View at Scopus
  33. C. Festuccia, G. L. Gravina, A. M. D'Alessandro et al., “Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models,” Endocrine-Related Cancer, vol. 16, no. 2, pp. 401–413, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Bruzzese, E. Di Gennaro, A. Avallone et al., “Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-α in head and neck cancer cells in vitro and in vivo,” Clinical Cancer Research, vol. 12, no. 2, pp. 617–625, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. U. D. Kahlert, G. Nikkhah, and J. Maciaczyk, “Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas,” Cancer Letters, vol. 331, no. 2, pp. 131–138, 2013. View at Google Scholar
  36. H. Li, J. Huang, B. Yang et al., “Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway,” Toxicology and Applied Pharmacology, vol. 272, no. 1, pp. 180–190, 2013. View at Google Scholar
  37. J. Ferlay, D. M. Parkin, and E. Steliarova-Foucher, “Estimates of cancer incidence and mortality in Europe in 2008,” European Journal of Cancer, vol. 46, no. 4, pp. 765–781, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. E. F. Burgess and D. Raghavan, “Prostate cancer: what did we learn from the 2012 Annual Scientific Meeting of ASCO?” Oncology (Williston Park), vol. 26, no. 12, pp. 1216–1221, 2012. View at Google Scholar
  39. B. A. Hadaschik, R. D. Sowery, and M. E. Gleave, “Novel targets and approaches in advanced prostate cancer,” Current Opinion in Urology, vol. 17, no. 3, pp. 182–187, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Y. Wu, Y. P. Tsai, M. Z. Wu, S. C. Teng, and K. J. Wu, “Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition,” Trends in Genetics, vol. 28, no. 9, pp. 454–463, 2012. View at Google Scholar
  41. Q. Gao, W. Liu, J. Cai et al., “EphB2 promotes cervical cancer progression by inducing epithelial-mesenchymal transition,” Human Pathology, vol. 45, no. 2, pp. 372–381, 2014. View at Google Scholar
  42. H. Whiteland, S. Spencer-Harty, D. H. Thomas et al., “Putative prognostic epithelial-to-mesenchymal transition biomarkers for aggressive prostate cancer,” Experimental and Molecular Pathology, vol. 95, no. 2, pp. 220–226, 2013. View at Google Scholar